Tenon Medical, Inc.

NasdaqCM TNON

Tenon Medical, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2024: USD -13.73 M

Tenon Medical, Inc. Operating Income is USD -13.73 M for the Trailing 12 Months (TTM) ending September 30, 2024, a 33.05% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

Tenon Medical, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -20.51 M, a -53.56% change year over year.
Tenon Medical, Inc. Operating Income for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -13.36 M.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

NasdaqCM: TNON

Tenon Medical, Inc.

CEO	Mr. Steven M. Foster
IPO Date	April 27, 2022
Location	United States
Headquarters	104 Cooper Court
Employees	21
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.

Key trends

Past 5 years